GALMED PHARMACEUTICALS LTD. Current Assets
GALMED PHARMACEUTICALS LTD. (GLMD) had Current Assets of $11.71 million as of 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-09-02
- 2026-06-30: Assets, Current $11.71M.
- 2025-12-31: Assets, Current $18.63M.
- 2025-09-30: Assets, Current $19.72M.
- 2025-06-30: Assets, Current $21.08M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $11.71M 6-K · filed 2026-09-02 |
| 2025-12-31 | $18.63M 6-K · filed 2026-09-02 |
| 2025-09-30 | $19.72M 6-K · filed 2025-11-26 |
| 2025-06-30 | $21.08M 6-K · filed 2025-08-28 |
| 2024-12-31 | $16.12M 20-F · filed 2026-03-31 |
| 2024-06-30 | $10.08M 6-K · filed 2024-08-28 |
| 2023-12-31 | $13.24M 20-F · filed 2025-04-02 |
| 2023-06-30 | $9.79M 6-K · filed 2023-08-09 |
| 2022-12-31 | $14.72M 20-F · filed 2024-04-04 |
| 2022-06-30 | $23.13M 6-K · filed 2022-08-04 |
| 2021-12-31 | $36.05M 20-F · filed 2023-03-29 |
| 2021-06-30 | $51.66M 6-K · filed 2021-08-05 |
| 2020-12-31 | $51.81M 20-F · filed 2022-05-02 |
| 2020-06-30 | $64.21M 6-K · filed 2020-08-06 |
| 2019-12-31 | $76.43M 20-F · filed 2021-03-18 |
| 2019-06-30 | $84.33M 6-K · filed 2019-08-05 |
| 2018-12-31 | $90.41M 20-F · filed 2020-03-12 |
| 2018-06-30 | $94.47M 6-K · filed 2018-08-02 |
| 2017-12-31 | $19.15M 20-F · filed 2019-03-13 |
| 2017-06-30 | $9.42M 6-K · filed 2017-07-31 |
| 2016-12-31 | $15.73M 20-F · filed 2018-03-13 |
| 2016-06-30 | $17.16M 6-K · filed 2017-06-23 |
| 2015-12-31 | $23.38M 6-K · filed 2017-06-23 |
| 2014-12-31 | $32.15M 20-F · filed 2016-03-22 |
| 2013-12-31 | $153.00K 20-F · filed 2015-03-31 |